ALDERLEY PARK VENTURES LIMITED

Active Nottingham

Activities of venture and development capital companies

0 employees website.com
Activities of venture and development capital companies
A

ALDERLEY PARK VENTURES LIMITED

Activities of venture and development capital companies

Founded 10 Oct 2014 Active Nottingham, United Kingdom 0 employees website.com
Activities of venture and development capital companies
Accounts Submitted 19 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 28 Oct 2025 Next due 20 Oct 2026 5 months remaining
Net assets £3M £253K 2024 year on year
Total assets £3M £255K 2024 year on year
Total Liabilities £6K £2K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Biocity Pennyfoot Street Nottingham NG1 1GF

Full company profile for ALDERLEY PARK VENTURES LIMITED (09259444), an active company based in Nottingham, United Kingdom. Incorporated 10 Oct 2014. Activities of venture and development capital companies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£526.00k

Increased by £505.00k (+2405%)

Net Assets

£3.44M

Increased by £253.00k (+8%)

Total Liabilities

£6.00k

Increased by £2.00k (+50%)

Turnover

N/A

Employees

N/A

Decreased by 2 (-100%)

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Glenn CrockerDirectorBritishEngland6231 Aug 2017Active
Joanne KelleyDirectorBritishEngland664 Jul 2017Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Astrazeneca Uk Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Significant Influence Or Control

Biocity Group Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

ALDERLEY PARK VENTURES LIMITED Current Company
FAST BIOPHARMA LTD united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Nov 2025OfficersChange to director Dr Glenn Crocker on 4 Nov 2025
5 Nov 2025OfficersChange to director Dr Glenn Crocker on 3 Nov 2025
4 Nov 2025OfficersChange to director Dr Glenn Crocker on 23 Oct 2025
4 Nov 2025OfficersChange to director Dr Glenn Crocker on 3 Nov 2025
28 Oct 2025Confirmation StatementConfirmation statement made on 6 Oct 2025 with no updates
5 Nov 2025 Officers

Change to director Dr Glenn Crocker on 4 Nov 2025

5 Nov 2025 Officers

Change to director Dr Glenn Crocker on 3 Nov 2025

4 Nov 2025 Officers

Change to director Dr Glenn Crocker on 23 Oct 2025

4 Nov 2025 Officers

Change to director Dr Glenn Crocker on 3 Nov 2025

28 Oct 2025 Confirmation Statement

Confirmation statement made on 6 Oct 2025 with no updates

Recent Activity

Latest Activity

Change to director Dr Glenn Crocker on 4 Nov 2025

6 months ago on 5 Nov 2025

Change to director Dr Glenn Crocker on 3 Nov 2025

6 months ago on 5 Nov 2025

Change to director Dr Glenn Crocker on 23 Oct 2025

6 months ago on 4 Nov 2025

Change to director Dr Glenn Crocker on 3 Nov 2025

6 months ago on 4 Nov 2025

Confirmation statement made on 6 Oct 2025 with no updates

6 months ago on 28 Oct 2025